{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:13:46Z","timestamp":1768724026577,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1995,12,1]],"date-time":"1995-12-01T00:00:00Z","timestamp":817776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[1995,12]]},"DOI":"10.1007\/bf01534569","type":"journal-article","created":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T05:42:48Z","timestamp":1113889368000},"page":"651-667","source":"Crossref","is-referenced-by-count":9,"title":["Blood polymorphonuclear leukocyte migratory activities during rheumatoid arthritis"],"prefix":"10.1007","volume":"19","author":[{"given":"Gerd","family":"Egger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"Aglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Rainer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF01534440","volume":"18","author":"G. Egger","year":"1994","unstructured":"Egger, G., C. Klemt, S. Spendel, W. Kaulfersch, andH. Kenzian. 1994. Migratory activity of blood polymorphonuclear leukocytes during juvenile rheumatoid arthritis, demonstrated with a new whole-blood membrane filter assay.Inflammation 18:427?441.","journal-title":"Inflammation"},{"key":"CR2","unstructured":"Cassidy, J. T. 1993. Juvenile rheumatoid arthritis.In Textbook of Rheumatology. W. N. Kelley, E. D. Harris, S. Ruddy, and C. B. Sledge, editors. W. B. Saunders Company, pp. 1189?1208."},{"key":"CR3","unstructured":"Harris, E. D. Etiology and pathogenesis of rheumatoid arthritis.In Textbook of rheumatology, W. N. Kelley, E. D. Harris, S. Ruddy, and C. B. Sledge, editors. W. B. Saunders Company. pp. 833?873."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"F. C. Arnett","year":"1988","unstructured":"Arnett, F. C., S. M. Edworthy, D. A. Bloch, et al. ((18 authors)) 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthr. Rheum. 31:315?324.","journal-title":"Arthr. Rheum."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jama.1949.02900430001001","volume":"140","author":"O. Steinbrocker","year":"1949","unstructured":"Steinbrocker, O., C. H. Traeger, andR. C. Batterman. 1949. Therapeutic criteria in rheumatoid arthritis.J. Amer. Med. Ass. 140:659?663.","journal-title":"J. Amer. Med. Ass."},{"key":"CR6","first-page":"997","volume":"18","author":"T. Pincus","year":"1991","unstructured":"Pincus, T., R. H. Brooks, andL. F. Callahan. 1991. Reliability of grip strength, walking time and button test performed according to a standard protocol.J. Rheumatol. 18:997?1000.","journal-title":"J. Rheumatol."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(74)90884-8","volume":"2","author":"E. C. Huscisson","year":"1974","unstructured":"Huscisson, E. C. 1974. Measurement of pain.Lancet 2:1127?1131.","journal-title":"Lancet"},{"key":"CR8","unstructured":"Harris, E. D. 1993. Treatment of rheumatoid arthritis.In Textbook of rheumatology. W. N. Kelley, E. D. Harris, S. Ruddy, and C. B. Sledge, editors. W. B. Saunders Company. pp. 912?923."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-1759(12)80056-1","volume":"149","author":"J. E. Rice","year":"1992","unstructured":"Rice, J. E., andL. P. Bignold. 1992. Chemotaxis of polymorphonuclear leukocytes in whole blood in the ?sparse pore? polycarbonate membrane\/Boyden chamber assay.J. Immunol. Methods 149:121?125.","journal-title":"J. Immunol. Methods"},{"key":"CR10","first-page":"50","volume-title":"Chemotaxis and inflammation","author":"P. C. Wilkinson","year":"1974","unstructured":"Wilkinson, P. C. 1974. Chemotaxis and inflammation. Churchill-Livingstone, Edinburgh and London, pp. 50?52."},{"key":"CR11","unstructured":"Kay, M. M. B. 1990. Immunologic problems.In Geriatric medicine. R. W. Schrier, editor. W. B. Saunders Company. pp. 376?395."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.ATV.12.7.836","volume":"12","author":"N. S. Key","year":"1992","unstructured":"Key, N. S., J. L. Platt, G. M. Vercellotti. 1992. Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils.Arterioscler. Thromb. 12:836?842.","journal-title":"Arterioscler. Thromb."},{"key":"CR13","first-page":"485","volume":"73","author":"P. G\u00f6r\u00f6g","year":"1992","unstructured":"G\u00f6r\u00f6g, P. 1992. Neutrophil-oxidized low density lipoprotein: generation in and clearance from the plasma.Int. J. Exp. Path. 73:485?490.","journal-title":"Int. J. Exp. Path."},{"key":"CR14","first-page":"725","volume":"31","author":"E. Wieland","year":"1993","unstructured":"Wieland, E., A. Brandes, V. W. Armstrong, andM. Oellerich. 1993. Oxidative modification of low density lipoproteins by human polymorphonuclear leukocytes.Eur. J. Clin. Chem. Clin. Biochem. 31:725?731.","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/01.ATV.12.7.824","volume":"12","author":"H.-A. Lehr","year":"1992","unstructured":"Lehr, H.-A., M. Becker, S. L. Marklund, C. H\u00fcbner, K. E. Erfors, A. Kohlsch\u00fctter, andK. Messmer. 1992. Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDLin vivo.Arterioscler. Thromb. 12:824?829.","journal-title":"Arterioscler. Thromb."},{"key":"CR16","first-page":"55","volume-title":"Inflammation. Basic principles and clinical correlates","author":"I. M. Goldstein","year":"1988","unstructured":"Goldstein, I. M. 1988. Complement: Biologically active products.In Inflammation. Basic principles and clinical correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, editors. Raven Press, New York. pp. 55?74."},{"key":"CR17","first-page":"195","volume-title":"Inflammation. Basic principles and clinical correlates","author":"C. A. Dinarello","year":"1988","unstructured":"Dinarello, C. A. 1988. Cytokines: Interleukin-1 and tumor necrosis factor (cachectin).In Inflammation. Basic principles and clinical correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, editors. Raven Press, New York. pp. 195?208."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1096\/fasebj.3.5.2784116","volume":"3","author":"L. I. Woldawer","year":"1989","unstructured":"Woldawer, L. I., M. A. Marano, H. Wei, Y. Fong, M. L. Silen, G. Kuo, K. R. Manogue, H. Vlassar, H. Cohen, andA. Cerami. 1989. Cachectin\/tumor necrosis factor alters red blood kinetics and induces anemia in vivo.FASEB J. 3:1637?1643.","journal-title":"FASEB J."},{"key":"CR19","first-page":"139","volume-title":"The acute-phase response to injury and infection","author":"A. Koy","year":"1985","unstructured":"Koy, A. 1985. Definition and classification of acute-phase proteins.In The acute-phase response to injury and infection. A. H. Gordon and A. Koj, editors. Elsevier, Amsterdam, pp. 139?144."},{"key":"CR20","first-page":"192","volume-title":"Interleukin-1, Inflammation and Disease","author":"J. T. Whicher","year":"1989","unstructured":"Whicher, J. T., J. Gauldie, H. Baumann, andC. Westacott. 1989. Acute phase proteins.In Interleukin-1, Inflammation and Disease. R. Bomford and B. Henderson, editors. Elsevier, Amsterdam, pp. 192?216."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4471-1739-1_13","volume-title":"Acute phase proteins in the acute phase response","author":"M. H. Ruswijk Van","year":"1989","unstructured":"Van Ruswijk, M. H., andM. A. Van Leeuwen. 1989. C-reactive protein: Clinical aspects.In Acute phase proteins in the acute phase response. M. B. Pepys, editor. Springer-Verlag, London, pp. 161?168."},{"key":"CR22","first-page":"205","volume-title":"The acute-phase response to injury and infection","author":"A. Koj","year":"1985","unstructured":"Koj. A. 1985. Regulation of synthesis of acute-phase proteins.In The acute-phase response to injury and infection. A. H. Gordon and A. Koy, editors. Elsevier, Amsterdam, pp. 205?220."},{"key":"CR23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/rhe1.1963.9.issue-1-4.29","volume":"9","author":"E. H. Gaulhofer De Klerch","year":"1963","unstructured":"Gaulhofer De Klerch, E. H., andG. van Dam. 1963. Septic complications in rheumatoid arthritis.Acta Rheumatol. Scand. 9:254?263.","journal-title":"Acta Rheumatol. Scand."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/art.1780140119","volume":"14","author":"J. Baum","year":"1971","unstructured":"Baum, J. 1971. Infection in rheumatoid arthritis.Arthritis Rheum. 14:135?137.","journal-title":"Arthritis Rheum."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/ard.31.2.118","volume":"31","author":"E. C. Huskisson","year":"1972","unstructured":"Huskisson, E. C. andF. H. Hart. 1972. Severe, unusual and recurrent infections in rheumatoid arthritis.Ann. Rheum. Dis. 31:118?121.","journal-title":"Ann. Rheum. Dis."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.1780300711","volume":"30","author":"J. P. Vandenbroucke","year":"1987","unstructured":"Vandenbroucke, J. P., R. Kaaks, H. A. Valkenburg, J. W. Boersma, A. Cats, J. J. Festen, A. P. Hartman, O. Huber-Bruning, J. J. Rasker, J. Weber, 1987. Frequency of infections among rheumatoid patients, before and after disease onset.Arthritis Rheum. 30:810?813.","journal-title":"Arthritis Rheum."},{"key":"CR27","unstructured":"Harris, E. D. 1993. Clinical features of rheumatoid arthritis: Vasculitis.In Textbook of rheumatology. W. N. Kelley, E. D. Harris, S. Ruddy, and C. B. Sledge, editors. W. B. Saunders Company, pp. 897?898."},{"key":"CR28","first-page":"703","volume-title":"Inflammation. Basic principles and clinical correlates","author":"P. Kadison","year":"1988","unstructured":"Kadison, P. andB. F. Haynes. 1988. Vasculitis: Mechanisms of vessel damage.In Inflammation. Basic principles and clinical correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, editors. Raven Press, New York: pp. 703?718."},{"key":"CR29","first-page":"427","volume":"40","author":"R. Anderson","year":"1991","unstructured":"Anderson R., C. E. J. Van Rensburg, G. K. Jonee, andA. Lessing. 1991. Auranofin inactivates phosphofructokinase in human neutrophils, leading to depletion of intracellular ATP and inhibition of superoxide generation and locomotion.Molecular Pharmacol. 40:427?434.","journal-title":"Molecular Pharmacol."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/ard.52.8.595","volume":"52","author":"J. G. R. Elferink","year":"1993","unstructured":"Elferink, J. G. R., andB. M. De Koster. 1993. Potentiation and inhibition of migration of human neutrophils by auranofin.Ann. Rheum. Dis. 52:595?598.","journal-title":"Ann. Rheum. Dis."},{"key":"CR31","first-page":"1453","volume":"18","author":"M. M. Corkill","year":"1991","unstructured":"Corkill, M. M., B. W. Kirkham, D. O. Haskard, C. Barbatis, T. Gibson, andG. S. Panayi. 1991. Gold treatment of rheumatoid arthritis decreases synovial expression of the endothelial leukocyte adhesion receptor ELAM-1.J. Rheumatol. 18:1453?1460.","journal-title":"J. Rheumatol."},{"key":"CR32","unstructured":"Rynes, R. I. 1993. Antimalaria drugs.In Textbook of rheumatology. W. N. Kelley, E. D. Harris, S. Ruddy, and C. B. Sledge, editors. W. B. Saunders Company. pp. 731?742."},{"key":"CR33","unstructured":"Day, R. O. 1993. Sulfasalazine.In Textbook of rheumatology. W. N. Kelley, E. D. Harris, S. Ruddy, and C. B. Sledge, editors. W. B. Saunders Company. pp. 692?699."},{"key":"CR34","unstructured":"Weinblatt, M. E. 1993. Methotrexate.In Textbook of rheumatology. W. N. Kelley, E. D. Harris, S. Ruddy, and C. B. Sledge, editors. W. B. Saunders Company, pp. 767?778."},{"key":"CR35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/ard.51.8.946","volume":"13","author":"V. A. Denis","year":"1992","unstructured":"Denis, V. A., G. M. Franic, D. A. Rathen, R. M. Laurent, andP. M. Brooks. 1992. Circulating cytokine levels in patients with rheumatoid arthritis: Results of a double blind trial with sulfasalazine.Ann. Rheum. Dis. 13:946?950.","journal-title":"Ann. Rheum. Dis."},{"key":"CR36","first-page":"524","volume":"19","author":"R. E. Wolf","year":"1992","unstructured":"Wolf, R. E., W. G. Brelsford, V. C. Hall, andS. B. Adams. 1992. Cytokines and soluble interleukin-2 receptors in rheumatoid arthritis.J. Rheumatol. 19:524?528.","journal-title":"J. Rheumatol."},{"key":"CR37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF02207957","volume":"11","author":"L. Altomonte","year":"1992","unstructured":"Altomonte, L., A. Zoli, L. Mirone, P. Scolieri, andM. Magaro. 1992. Serum levels of interleukin-lb, tumor necrosis factor-\u00ab and interleukin-2 in rheumatoid arthritis. Correlation with disease activity.Clin. Rheumatol. 11:202?205.","journal-title":"Clin. Rheumatol."},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/art.1780360807","volume":"36","author":"P. Barrera","year":"1993","unstructured":"Barrera, P., A. M. Boerbooms, E. M. Janssen, R. W. Sauerwein, H. Galatti, J. Mulder, T. De Boo, P. M. Demacker, L. B. Van Der Putte, andJ. W. van der Meer. 1993. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.Arthritis Rheum. 36:1070?1079.","journal-title":"Arthritis Rheum."},{"key":"CR39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0955-2235(92)90022-A","volume":"4","author":"M. Feldmann","year":"1992","unstructured":"Feldmann, M., F. M. Brennan, R. O. Williams, A. P. Cope, D. L. Gibbons, P. D. Katsikis, andR. N. Maini. 1992. Evaluation of the role of cytokines in autoimmune disease: The importance of TNF alpha in rheumatoid arthritis.Progr. Growth Factor Res. 4:247?255.","journal-title":"Progr. Growth Factor Res."}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01534569\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01534569.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01534569\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01534569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T13:45:23Z","timestamp":1556891123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01534569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,12]]}},"alternative-id":["BF01534569"],"URL":"https:\/\/doi.org\/10.1007\/bf01534569","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,12]]}}}